Conditions: Atopic Disease (Including Allergic Conjunctivitis)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 512
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety of AC-170 0.24% used twice daily in Healthy Adult Subjects and in Pediatric subjects with a history or family history of atopic disease (including allergic conjunctivitis).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Drug: AC-170 0.24% intervention 2: AC-170 0%
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: